Getinge Gains as Nordea Sees Europe Stabilizing: Stockholm Mover

Getinge AB (GETIB), a Swedish maker of sterilization systems, rose the most in three weeks after Nordea Bank AB (NDA) said demand is probably stabilizing in Europe.

The shares gained as much as 2 percent, the biggest intraday advance since June 11, and traded 1.9 percent higher at 209.80 kronor as of 10:14 a.m. in Stockholm trading, giving the company a market value of 50 billion kronor ($7.5 billion).

“The impression we get from our industry contacts is that demand for medical technology capital equipment has begun to stabilize in Europe,” Patrik Ling, an analyst at Nordea, said in a note. “The underlying demand is still weak but we believe the bottom has been reached around mid-2013 –- which is good for Getinge’s mid-term outlook.”

Nordea lifted its share-price estimate for Getinge to 200 kronor from 185 kronor on the back of “slightly higher” forecasts for the coming years. The bank reiterated a sell recommendation as it expects Getinge’s second-quarter results, due July 11, to be weaker than its management expected at the time of the first-quarter report.

To contact the reporter on this story: Katarina Gustafsson in Stockholm at

To contact the editor responsible for this story: David Risser at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.